Elevated levels of serum lipids and lipoproteins are known to play a major role in the
development of atherosclerosis and subsequent coronary heart disease (CHD). In controlled …

Atorvastatin and simvastatin are both effective in lowering LDL-C and TC in hyperlipidemic
patients. The usual starting dose for both agents is 10 mg once daily, although for …

This 1-year, double-blind, active-controlled, multicenter study compared the efficacy and
safety of atorvastatin to pravastatin and evaluated their ability to achieve target low-density …

Background: High levels of total and LDL-cholesterol are associated with an increased risk
of atherosclerotic vascular disease. Lowering of serum cholesterol levels by pharmacologic …

Lowering of serum cholesterol levels by pharmacologic intervention with statins reduces the
incidence of cardiovascular events in subjects with and without atherosclerotic …

In this 2-year study, 787 patients with hypercholesterolemia received either atorvastatin 10
mg to 80 mg/day (623 patients) or lovastatin 20 mg to 80 mg/day (164 patients). Patients …

Plasma cholesterol and other lipoproteins play a significant role in the development of
atherosclerosis and subsequent coronary heart disease (CHD). This 1 year study was …

Hyperlipidemia is a major risk factor for coronary heart disease (CHD). It is now well
established that reducing increased LDL-C levels can significantly reduce the risk of CHD …

Current information on the utilisation of atorvastatin under clinical practice conditions is
limited. The cross sectional study DISCOVER documented in the period from June until …

Preclinical and clinical data on atorvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A
(HMG-CoA) reductase inhibitor, indicate that it has superior activity in treating a variety of …